Erasca updates ERAS-0015 data, plans registration-enabling trials, reports Q2 2026 resultsAug 11Quarterly updateERAS-0015Erasca, Inc.
Amgen posts results for three rocatinlimab Phase 3 trials, plus CodeBreak300 and AMG 133 updatesJul 24Weekly roundup, 5 itemsAmgenmaridebart cafraglutide
Sign inSign in